Phase II Study of Biweekly Pemetrexed Plus Irinotecan as Second-Line Therapy for Metastatic Colorectal Cancer

por Louvet, C., André, T., Gamelin, E., Hebbar, M., Mabro, M., Bennamoun, M., Rassam, H., de Gramont, A.
Publicado 2010

A phase II study of FOLFIRI-3 (double infusion of irinotecan combined with LV5FU) after FOLFOX in advanced colorectal cancer patients

por Mabro, M, Artru, P, André, T, Flesch, M, Maindrault-Goebel, F, Landi, B, Lledo, G, Plantade, A, Louvet, C, de Gramont, A
Publicado 2006

Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly

por Aparicio, T, Desramé, J, Lecomte, T, Mitry, E, Belloc, J, Etienney, I, Montembault, S, Vayre, L, Locher, C, Ezenfis, J, Artru, P, Mabro, M, Dominguez, S
Publicado 2003